Showing results (121-130 of 232) with videos related to
Sort By:
Pageof 24
Molecular & Cellular Proteomics : MCP|February 17, 2012
Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantationDaniela M Schlatzer, Jean-Eudes Dazard, Rob M Ewing, et al.Molecular & Cellular Proteomics : MCP|February 11, 2005
Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluidsHong Wang, Shawn G Clouthier, Vladimir Galchev, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndromeGerhard C Hildebrandt, Leigh A Corrion, Krystyna M Olkiewicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.Blood|October 24, 2002
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantationJoseph H Antin, Daniel Weisdorf, Donna Neuberg, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2020
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials NetworkJohn E Levine, Joseph H Antin, Carl E Allen, et al.Blood Advances|April 19, 2024
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignanciesPhilip H Imus, Sergiu Pasca, Hua-Ling Tsai, et al.Blood Advances|January 22, 2026
Bone marrow transplantation for sickle cell disease using post-transplantation cyclophosphamide and 400 cGy TBIMarti Goldenberg, Ravi Varadhan, Christopher J Gamper, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007James L M Ferrara, Claudio Anasetti, Edward Stadtmauer, et al.Science Translational Medicine|December 20, 2023
Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effectsMariano Prado-Acosta, Seihwan Jeong, Alberto Utrero-Rico, et al.Pageof 24